Home  >  Products  >  CD207 (CD207 molecule, langerin ) Blocking Peptide (the C terminal of CD207)(100ug)
CD207 (CD207 molecule, langerin ) Blocking Peptide (the C terminal of CD207)(100ug)

CD207 (CD207 molecule, langerin ) Blocking Peptide (the C terminal of CD207)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CD207 Antibody (ARP63502_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63502
Size: 100ug
Weight: 36kDa
Gene: 50489
Format: Lyophilized powder
Target: The protein encoded by this gene is expressed only in Langerhans cells which are immature dendritic cells of the epidermis and mucosa. It is localized in the Birbeck granules, organelles present in the cytoplasm of Langerhans cells and consisting of superimposed and zippered membranes. It is a C-type lectin with mannose binding specificity, and it has been proposed that mannose binding by this protein leads to internalization of antigen into Birbeck granules and providing access to a nonclassical antigen-processing pathway. Mutations in this gene result in Birbeck granules deficiency or loss of sugar binding activity.
Alternative names: CLEC4K
See Full Product Listings >